The Changing Landscape of Substance Use Disorders
Publication: FOCUS, A Journal of the American Psychiatric Association
This section contains a compilation of recent publications that have shaped the thinking in the field as well as classic works that remain important to the subject reviewed in this issue. This bibliography has been compiled by experts in the field and members of the editorial and advisory boards. Entries are listed chronologically and within topics and years by first author. Articles from the bibliography that are reprinted in this issue are in bold type.
2019
Lowe DJE, Sasiadek JD, Coles AS, et al: Cannabis and mental illness: a review. Eur Arch Psychiatry Clin Neurosci 2019; 269:107–120
Nielsen S, Gowing L, Sabioni P, et al: Pharmacotherapies for cannabis dependence. Cochrane Database Syst Rev 2019; 1:CD008940
Sullivan MA, Bisaga A, Pavlicova M, et al: A randomized trial comparing extended-release injectable suspension and oral naltrexone, both combined with behavioral therapy, for the treatment of opioid use disorder. Am J Psychiatry 2019; 176:129–137
Uhl GR, Koob GF, Cable J: The neurobiology of addiction. Ann N Y Acad Sci 2019
Vermeulen J, Schirmbeck F, Blankers M, et al: Smoking, symptoms, and quality of life in patients with psychosis, siblings, and healthy controls: a prospective, longitudinal cohort study. Lancet Psychiatry 2019; 6:25–34
2018
Brezing CA, Levin FR: The current state of pharmacological treatments for cannabis use disorder and withdrawal. Neuropsychopharmacology 2018; 43:173–194
Crescenzo F, Ciabattini M, Cipriani A et al. Comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine addiction: a systematic review and network meta-analysis. PLoS Med. 2018 Dec 26;15(12):e1002715.
Deng H, Verrico CD, Kosten TR, et al: Psychosis and synthetic cannabinoids. Psychiatry Res 2018; 268:400–412
Farahzadi MH, Moazen-Zadeh E, Razaghi E, et al: Riluzole for treatment of men with methamphetamine dependence: a randomized, double-blind, placebo-controlled clinical trial. J Psychopharmacol 2018; 33:305–315
Hurt RT, Ebbert JO, Croghan IT, et al: Varenicline for tobacco-dependence treatment in alcohol-dependent smokers: a randomized controlled trial. Drug Alcohol Depend 2018; 184:12–17
Larochelle MR, Bernson D, Land T, et al: Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study. Ann Intern Med 2018; 169:137–145
Lee JD, Nunes EV Jr, Novo P, et al: Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial. Lancet 2018; 391:309–318
Reus VI, Fochtmann LJ, Bukstein O, et al: The American Psychiatric Association practice guideline for the pharmacological treatment of patients with alcohol use disorder. Am J Psychiatry 2018; 175:86–90
Sabioni P, Le Foll B: Psychosocial and pharmacological interventions for the treatment of cannabis use disorder. F1000 Res 2018; 7:173
Scott JC, Slomiak ST, Jones JD, et al: Association of cannabis with cognitive functioning in adolescents and young adults: a systematic review and meta-analysis. JAMA Psychiatry 2018; 75:585–595
Volkow ND, Jones EB, Einstein EB, et al: Prevention and treatment of opioid misuse and addiction: a review. JAMA Psychiatry 2019; 76:208–216
Zehra A, Burns J, Liu CK, et al: Cannabis addiction and the brain: a review. J Neuroimmune Pharmacol 2018; 13:438–452
2017
Bahorik AL, Leibowitz A, Sterling SA, et al: Patterns of marijuana use among psychiatry patients with depression and its impact on recovery. J Affect Disord 2017; 213:168–171
Carroll KM, Kiluk BD: Cognitive behavioral interventions for alcohol and drug use disorders: through the stage model and back again. Psychol Addict Behav 2017; 31:847–861
Carroll KM, Weiss RD: The role of behavioral interventions in buprenorphine maintenance treatment: a review. Am J Psychiatry 2017; 174:738–747
Hassan AN, Howe AS, Samokhvalov AV, et al: Management of mood and anxiety disorders in patients receiving opioid agonist therapy: review and meta-analysis. Am J Addict 2017; 26:551–563
Hser YI, Huang D, Saxon AJ, et al: Distinctive trajectories of opioid use over an extended follow-up of patients in a multisite trial on buprenorphine+naloxone and methadone. J Addict Med 2017; 11:63–69
Klaman SL, Isaacs K, Leopold A, et al: Treating women who are pregnant and parenting for opioid use disorder and the concurrent care of their infants and children: literature review to support national guidance. J Addict Med 2017; 11:178–190
Sordo L, Barrio G, Bravo MJ, et al: Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ 2017; 357:j1550
Webster LR: Risk factors for opioid-use disorder and overdose. Anesth Analg 2017; 125:1741–1748
Further Reading
Blanco C, Rafful C, Wall MM, et al: Towards a comprehensive developmental model of cannabis use disorders. Addiction 2014; 109:284–294
Gates PJ, Sabioni P, Copeland J, et al: Psychosocial interventions for cannabis use disorder. Cochrane Database Syst Rev 2016; (5):CD005336
Humphreys K, Blodgett JC, Wagner TH: Estimating the efficacy of Alcoholics Anonymous without self-selection bias: an instrumental variables re-analysis of randomized clinical trials. Alcohol Clin Exp Res 2014; 38:2688–2694
Tang YY, Tang R, Posner MI: Mindfulness meditation improves emotion regulation and reduces drug abuse. Drug Alcohol Depend 2016; 163(Suppl 1):S13–S18 [Review]
Yuodelis-Flores C, Ries RK: Addiction and suicide: a review. Am J Addict 2015; 24:98–104
Zulauf CA, Sprich SE, Safren SA, et al: The complicated relationship between attention deficit/hyperactivity disorder and substance use disorders. Curr Psychiatry Rep 2014; 16:436
Information & Authors
Information
Published In
FOCUS, A Journal of the American Psychiatric Association
Pages: 152 - 153
History
Published in print: Spring 2019
Published online: 11 April 2019
Authors
Metrics & Citations
Metrics
Citations
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
View Options
View options
PDF/EPUB
View PDF/EPUBLogin options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).